Selected Publications
Jessica M. Stempel, Geoffrey L. Uy, Shira N. Dinner, Ivana Gojo, Daniel R Reed, Rupali Roy, Kenneth P Byrd, Swaroopa Yerrabothala, Catherine E. Lai, Kimberley Doucette, Anne Caldwell, Ondrej Blaha, Nikolai A. Podoltsev, Lourdes M Mendez, Jan Philipp Bewersdorf, Tariq Kewan, Ignacio Wistuba, Gheath Alatrash, Cara L Haymaker, Howard Streicher, Elad Sharon, Richard F. Little, Steven D. Gore, Jerald P. Radich, Brent L. Wood, Amer M. Zeidan, Rory M. Shallis: Efficacy and Safety of Pembrolizumab Added to Azacitidine Plus Venetoclax for Patients with Acute Myeloid Leukemia: Results from an Investigator-Initiated, Multi-Center, CTEP-Sponsored Randomized, Phase II Trial (BLAST AML-2) Blood : 2024.
Catherine E. Lai, Thomas P. Leahy, Alex Turner, Amber Thomassen, Lixia Wang, Aaron Sheppard, Jorge E. Cortes: Effectiveness of Olutasidenib Versus Ivosidenib in Patients with Mutated Isocitrate Dehydrogenase 1 Acute Myeloid Leukemia Who Are Relapsed or Refractory to Venetoclax: The 2102-HEM-101 Trial Versus a US Electronic Health Record-Based External Control Arm Blood : 2024.
Margaret Rowe, Daria Babushok, Martin Carroll, Alison Carulli, Noelle Frey, Saar Gill, Elizabeth Hexner, Rebecca Hirsh, Nasheed Hossain, Catherine Lai, Alison Loren, Selina Luger, Ivan Maillard, Shannon McCurdy, Andrew Matthews, Mary Ellen Martin, Vikram R Paralkar, Alexander Perl, David Porter, Keith Pratz, Edward Stadtmauer, Ximena Jordan Bruno: Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen European Journal of Haematology : 2024.
Catherine Lai, David Statman: Some acute myeloid leukemia patients can wait to start treatment HemOnc Today; Virtual Interview : 2024.
Catherine Lai, David Statman: Study examines FLT-3 inhibitors in leukemia treatment HemOnc Today, Virtual Interview : 2024.
Catherine Lai, David Statman: Menin inhibitors could significantly change leukemia treatment HemOnc Today; Virtual Interview : 2024.
Mark Roschewski, Christopher Melani, Rahul Lakhotia, Tatyana Gavrilova, Jagan R. Muppidi, James D. Phelan, Michail S. Lionakis, Kieron Dunleavy, Lode J. Swinnen, Matthias Holdhoff, Catherine E. Lai, Sami Ibrahimi, Michael Glantz, Jan Drappatz, John A. Butman, Stefania Pittaluga, Kim Johnson, Candis Morrison, Nick Micheletti, John D. Heiss, William D. Figg, Elaine S. Jaffe, S. Percy Ivy, Richard F. Little, Louis M. Staudt, Wyndham H. Wilson: Phase 1 Study of Escalating Doses of Ibrutinib in Teddi-R with Isavuconazole for Relapsed and Refractory Primary DLBCL of the CNS Blood : 2024.
Jayakumar Vadakekolathu, Sarah Skuli, David J Boocock, Clare Coveney, Eruchi G Ikpo, Bofei Wang, Elena M Fenu, Hussein A. Abbas, MD, Catherine E. Lai, Martin P Carroll, Sergio Rutella: Multi-Omic Analyses of TP53-Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures Blood : 2024.
Rowe, Margaret; Babushok, Daria V.; Carroll, Martin; Carulli, Alison; Frey, Noelle V.; Gill, Saar; Hexner, Elizabeth; Hirsh, Rebecca; Hossain, Nasheed; Lai, Catherine; Loren, Alison; Luger, Selina; Maillard, Ivan; McCurdy, Shannon R.; Matthews, Andrew; Martin, Mary Ellen; R, Vikram Paralkar; Perl, Alexander E.; Porter, David; Pratz, Keith W.; Stadtmauer, Edward; Bruno, Ximena Jordan: Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated with a Venetoclax Based Regimen: A Real World Single Center Experience European Journal of Haematology : 2024.
Lai C, Lee M, Bobek O, Le-Rademacher J, Mandrekar SJ, Roboz GJ, Uy GL, Mandelblatt J, Klepin HD.: Deficit accumulation frailty index (DAFI) and treatment tolerability in AML: Data from CALGB 11001 and 11002 (Alliance) Blood Adv : 2024.
Academic Contact Information
Abramson Cancer Center
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
12 South Pavillion
Philadelphia,
PA
19104
Phone: 215-349-8940
Patient appointments: 800-789-7366